A Kerala court has issued a bailable arrest warrant against Baba Ramdev and Acharya Balakrishna after allegations of misleading claims about Patanjali Ayurved products curing ailments like diabetes and high blood pressure. The case, triggered by complaints from ophthalmologist K.V. Babu, cites violations of the Drugs and Magic Remedies Act. This action follows the Supreme Court’s warning against unchecked misleading advertisements.
Thank you for reading this post, don't forget to subscribe!
KERALA: A Kerala court has issued a bailable arrest warrant against Yoga guru Baba Ramdev and his associate Acharya Balakrishna following a complaint filed by Kerala’s drug regulators. The complaint alleges that Patanjali Ayurved promoted misleading advertisements about its healthcare products.
The Palakkad district court issued the warrant on January 16, 2025, as reported by media.
The case originated from complaints raised by Kannur-based ophthalmologist K.V. Babu in 2023. His concerns prompted Kerala’s drugs control department to instruct its offices across the state to take legal action against Patanjali Ayurved.
The company allegedly violated the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 (DMR Act) by claiming their products could cure health conditions such as high blood pressure and diabetes.
These kinds of claims are explicitly prohibited under the DMR Act.
ALSO READ: [Breaking] Patanjali Fake Ads Case, SC Reserves Verdict in Contempt Of Court Against Patanjali
The court records for January 16, 2025, state:
“Complainant absent. All accused served. Bailable warrant to all accused.”
Dr. Babu initially raised his concerns in 2022, lodging complaints with both central and state authorities.
He even escalated his grievances to the Prime Minister’s Office in January 2024, underscoring the seriousness of his allegations.
ALSO READ: Patanjali Row | SC Orders Removal of Patanjali Ads, Suspends Sales of Restricted Products
This development aligns with the Supreme Court’s recent warnings to states and Union Territories about the consequences of ignoring misleading advertisements.
The court has threatened contempt action against those who fail to act against such violations.
This case serves as a significant example of legal action being taken to address potentially deceptive claims in the healthcare product industry, emphasizing the importance of regulatory oversight to protect consumers.
CASE TITLE:
Drugs Inspector Palakkad v. Divya Pharmacy and others | ST/0001525/2024
Click Here to Read Previous Reports on Baba Ramdev
FOLLOW US ON YOUTUBE FOR MORE LEGAL UPDATES
